Michael Eberhardson
Adjunct Associate Professor
Publications
2026
Impact of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis on Colorectal Cancer Risk: National Cohort Study
Clinical Gastroenterology and Hepatology, Vol. 24, p. 503-511
(Article in journal)
https://dx.doi.org/10.1016/j.cgh.2025.06.037
2025
Cumulative incidence and prevalence of perianal diseases in patients with inflammatory bowel disease and in the population: a nationwide Swedish study
Scandinavian Journal of Gastroenterology, Vol. 60, p. 349-354
(Article in journal)
https://dx.doi.org/10.1080/00365521.2025.2476669
Substantial Reduction of Systemic Corticosteroid Use After Primary Ileocaecal Resection in Swedish Patients With Crohn's Disease: A Population-Based Cohort Study
Alimentary Pharmacology and Therapeutics, Vol. 61, p. 1649-1661
(Article in journal)
https://dx.doi.org/10.1111/apt.70069
2024
Comparative study of a point-of-care test and an enzyme-linked immunosorbent assay (ELISA) for infliximab levels
Scandinavian Journal of Gastroenterology, Vol. 59, p. 150-155
(Article in journal)
https://dx.doi.org/10.1080/00365521.2023.2269456
2023
Therapeutic drug monitoring in inflammatory bowel disease: implementation, utilization, and barriers in clinical practice in Scandinavia
Scandinavian Journal of Gastroenterology, Vol. 58, p. 25-33
(Article in journal)
https://dx.doi.org/10.1080/00365521.2022.2108684